Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
Ryan Allway April 4th, 2023 Psychedelics, Top News Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )